Intravenous Tramadol is Effective in the Management of Postoperative Pain Following Abdominoplasty: A Three-Arm Randomized Placebo- and Active-Controlled Trial
Abstract Background and Objective Oral tramadol, an atypical opioid approved in the United States (US) since 1995 and a Schedule IV controlled substance, has less abuse liability compared to Schedule II conventional opioids. Intravenous (IV) tramadol is not available in the US, but has the potential...
Main Authors: | Harold Minkowitz, Hernan Salazar, David Leiman, Daneshvari Solanki, Lucy Lu, Scott Reines, Michael Ryan, Mark Harnett, Neil Singla |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-05-01
|
Series: | Drugs in R&D |
Online Access: | https://doi.org/10.1007/s40268-020-00309-0 |
Similar Items
-
Efficacy and Safety of Intravenously Administered Tramadol in Patients with Moderate to Severe Pain Following Bunionectomy: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study
by: Neil K. Singla, et al.
Published: (2020-07-01) -
IV Tramadol – A New Treatment Option for Management of Post-Operative Pain in the US: An Open-Label, Single-Arm, Safety Trial Including Various Types of Surgery
by: Minkowitz H, et al.
Published: (2020-05-01) -
Efficacy and Safety of Intravenous Meloxicam in Subjects with Moderate-to-severe Pain Following Abdominoplasty
by: Neil Singla, MD, et al.
Published: (2018-06-01) -
Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty
by: Matthew Bindewald, MD, et al.
Published: (2017-09-01) -
Misuse of Tramadol in the United States: An Analysis of the National Survey of Drug Use and Health 2002-2017
by: Scott A Reines, et al.
Published: (2020-06-01)